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Abstract
Significance: Reactive oxygen species (ROS) are often considered to be undesirable toxic molecules that are
generated under conditions of cellular stress, which can cause damage to critical macromolecules such as DNA.
However, ROS can also contribute to the pathogenesis of cancer and many other chronic inflammatory disease
conditions, including atherosclerosis, metabolic disease, chronic obstructive pulmonary disease, neurodegen-
erative disease, and autoimmune disease.
Recent Advances: The field of ROS biology is expanding, with an emerging paradigm that these reactive
species are not generated haphazardly, but instead produced in localized regions or in specific subcellular
compartments, and this has important consequences for immune system function. Currently, there is evidence
for ROS generation in extracellular spaces, in endosomal compartments, and within mitochondria. Intriguingly,
the specific location of ROS production appears to be influenced by the type of invading pathogen (i.e., bacteria,
virus, or fungus), the size of the invading pathogen, as well as the expression/subcellular action of pattern recognition
receptors and their downstream signaling networks, which sense the presence of these invading pathogens.
Critical Issues: ROS are deliberately generated by the immune system, using specific NADPH oxidases that are
critically important for pathogen clearance. Professional phagocytic cells can sense a foreign bacterium, initiate
phagocytosis, and then within the confines of the phagosome, deliver bursts of ROS to these pathogens. The
importance of confining ROS to this specific location is the impetus for this perspective.
Future Directions: There are specific knowledge gaps on the fate of the ROS generated by NADPH oxidases/
mitochondria, how these ROS are confined to specific locations, as well as the identity of ROS-sensitive targets
and how they regulate cellular signaling. Antioxid. Redox Signal. 32, 982–992.
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Why Is There a Need for Reactive Oxygen Species
Compartmentalization?
As the term reactive oxygen species (ROS) implies,ROS are highly reactive molecules and to a large degree
their site of generation will therefore determine their site of
action; but nonetheless, this must avoid off target effects. For
instance, superoxide anion, often referred to as the ‘‘parent’’
ROS, is generated by a variety of enzymatic and nonenzy-
matic systems in either a deliberate manner by enzymes
whose primary function is to generate ROS (i.e., NADPH
oxidases) or inadvertently as a consequence of a dysfunc-
tional variant of the system, such as uncoupled nitric oxide
synthase or in mitochondria. However, irrespective of how
the superoxide is generated, it is rapidly converted to hy-
drogen peroxide (H2O2), either spontaneously from the re-
action of two superoxide molecules or via enzymatic
catalysis using the superoxide dismutase (SOD) family of
enzymes; in a rapid process described by a rate constant of
*108 M/s. Moreover, superoxide can react with another
important molecule, nitric oxide (NO), to give rise to per-
oxynitrite (ONOO-), a very powerful oxidant with pleiotro-
pic actions (42). The reaction between superoxide and NO is
the fastest known biological reaction at *5 · 109 M/s and
therefore is highly diffusion limited. Thus, the overall level of
any particular ROS in a biological system is strictly con-
trolled by tight regulation of its enzymatic production, as well
as its removal or metabolism by highly efficient antioxidant
enzymes such as SOD, catalase, glutathione peroxidase and
peroxiredoxins, or soluble antioxidants such as glutathione
and ascorbate. This ROS chemistry has been the subject of
many comprehensive reviews by experts in the field (50, 51)
and therefore will not be covered in this perspective. How-
ever, it is becoming increasingly clear that cells have evolved
ways to compartmentalize ROS production, which ensures
localized signaling and restricts inadvertent effects of ROS
on other critical cellular machinery. For example, there is
emerging evidence that ROS production occurs in specific
compartments of the cell in response to invading microor-
ganisms. In the following sections, we will describe several
scenarios of distinct sites for ROS generation, with a brief
description of how these processes occur and particularly the
impact that they have on innate immune system function.
Phagosomal NOX2 Oxidase-Derived ROS Response
to Small Bacteria and Fungi
Unquestionably, the most highly characterized subcellular
compartment relating to ROS production is the phagosome.
In this specialized endocytic compartment, high concentra-
tions of ROS can be achieved and this has been referred to as
an ‘‘oxidative burst.’’ This process occurs primarily in neu-
trophils and macrophages after engulfing bacteria or fungi
and provides an initial line of host defense against these in-
vading pathogens (Fig. 1). This ROS generation is the pri-
mary function of an enzyme family called NADPH oxidases
and is distinct from other enzymes that produce ROS either as
a by-product of their normal catalytic activity or due to ab-
normal function during disease (3, 5, 7, 10, 11, 22, 25, 33, 39).
NADPH oxidase enzymes are expressed in most mammalian
cell types, where they catalyze the reduction of molecular
oxygen to generate superoxide (and/or H2O2) in various in-
tracellular and extracellular compartments. NADPH oxidases
are membrane-bound enzymes that utilize electrons from
cytosolic NADPH to catalyze ROS production, and there are
seven NADPH oxidase isoforms (5, 10). These NADPH
oxidases are expressed in different subcellular membrane
compartments, including the phagosome, endosome, mito-
chondria, endoplasmic reticulum (ER), and nucleus as well as
in association with the cell surface, for ROS production in the
extracellular space (10). However, a functional NADPH
oxidase is not always present in each of these compartments,
and this is part of the regulatory system that ensures that ROS
are only produced under specific conditions. For example,
when neutrophils or macrophages phagocytose bacteria or
fungi, this initiates a complex series of events, which includes
the assembly of the prototypical NOX2-containing NADPH
oxidase enzyme complex at the phagosomal membrane
(Fig. 1). This results in the capacity for electron transfer from
NADPH to the NOX2 catalytic subunit, which comprises a
single flavin adenine dinucleotide (FAD) molecule bound to
the extended carboxy-terminal tail of NOX2, and two pros-
thetic heme groups attached to histidine residues within the
FIG. 1. Schematic representation of the phagosomal
ROS production to ‘‘small’’ bacteria and fungi. Bacteria
and fungi can be internalized via phagocytosis initiating
phagosomal superoxide production by NOX2 oxidase and
then conversion to H2O2 and HOCl via MPO (in neutrophils,
mainly). Along with proteases, ROS are thought to ‘‘kill’’ the
invading bacteria or fungi. H2O2, hydrogen peroxide; HOCl,
hypochlorous acid; MPO, myeloperoxidase; ROS, reactive
oxygen species. Color images are available online.
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transmembrane region. Oxygen bound to heme acts as the
final electron acceptor resulting in the release of superoxide
from the enzyme within the phagosome compartment. This is
the natural direction of superoxide generation by phagosomal
NOX2 NADPH oxidase, owing to the topology of the NOX2
catalytic subunit and the conduit of electron accepting moi-
eties found within this subunit.
Even though it has been more than 80 years since the initial
discovery of the phagocytic oxidative burst by Baldridge and
Gerard, it is still largely unknown how the generation of
superoxide/ROS within the phagosome results in an anti-
bacterial response and how it impacts on the immune system
(4). This topic has been hotly debated, and multiple scenarios
have been emphasized. The first and more widely accepted
view is that superoxide generated within the phagosome is
converted by a series of enzymes to H2O2, that is, SOD and
then to the more powerful oxidizing species hypochlorous
acid (and other derivatives) by myeloperoxidase (MPO).
This powerful oxidizing environment effectively ‘‘bleaches’’
the bacterium or fungus and thereby eliminates the pathogen
(33). However, this widely held view of ROS being the ul-
timate mediator for pathogen killing has been contested,
particularly by Segal (37). Indeed, it was demonstrated that
the NOX2-containing oxidase of the neutrophil is critical for
pumping electrons into the phagocytic vacuole, and in the
process, inducing a charge differential across the membrane
that must be compensated. The compensating ion movement
produces conditions within the vacuole that are favorable to
bacterial killing and digestion by hydrolase enzymes that are
released into the vacuole from cytoplasmic granules, and not
killing by ROS directly. Perhaps, the most compelling data
arguing against ROS and oxidized halides serving as direct
microbicidal agents are provided by mice with suppressed
neutral granule proteases, cathepsin G, and elastase (34).
While these mice display normal superoxide/ROS generation
and normal iodination, as a consequence of normal MPO
activity, they are unable to kill Staphylococcus aureus and
Candida albicans, with a killing defect at least as severe as
that in the chronic granulomatous disease (CGD) mouse
lacking p47phox.
Extracellular NOX2 Oxidase-Derived ROS for Large
Bacteria and Fungi
The activation of NOX2 oxidase occurs within seconds of
degranulation and after vacuole closure, but in this case, the
superoxide is not detected in the extracellular space of the
cell that is phagocytosing the bacterium. However, if neu-
trophils are ‘‘frustrated’’ and the process of phagocytosis is
delayed or engulfment is not possible, superoxide can be
detected extracellularly (Fig. 2). It has been proposed that the
size of bacteria and fungi influences whether ROS production
occurs within the phagosome or extracellularly (48), and this
presumably relates to the capacity to easily phagocytose the
target pathogen. The localization of ROS generated in re-
sponse to pathogens of differing size is proposed to influence
immune signaling, interleukin (IL)-1b expression, and the
redox state of nuclear factor kappa B (NF-jB). For instance,
small bacteria and fungi that are phagocytosed activate
NOX2 to produce ROS intracellularly, presumably within the
phagosome (48). In these studies, the p50 subunit of NF-jB
underwent oxidation, and the inflammasome complex cou-
pled with IL-1b expression was suppressed, in a manner that
was blocked by diphenyleneiodonium chloride (DPI), a
widely used NADPH oxidase inhibitor. While inhibition by
DPI implies NADPH oxidase as a source of ROS, this in-
terpretation needs to be made cautiously, because at the
concentration used, that is, 10 lM, DPI will inhibit other
FAD-containing enzymes such as endothelial nitric oxide
synthase, xanthine oxidase, and proteins of the mitochondrial
electron transport chain (ETC) (1). In contrast to small mi-
crobes, neutrophils that fail to engulf larger microbes, such as
C. albicans, activate plasma membrane-bound NOX2 oxi-
dase and produce ROS in the extracellular space. Extra-
cellular ROS has been suggested to be delivered to this site by
endosomes undergoing exocytosis at the cell surface (i.e.,
endosomes are contiguous with the cell surface and contain
NOX2). However, this NOX2 oxidase is assembled at the
plasma membrane, and while the production of extracellular
ROS is believed to be involved in killing the Candida, it also
prevents oxidation of p50, which amplifies IL-1b expression.
Elevated IL-1b can stimulate stronger recruitment of neu-
trophils, which can then form clusters around large microbes.
Although these findings highlight the potential importance
of ROS localization in shaping the immune response, some of
the points raise additional questions. In particular, how
phagosomal ROS, generated in response to engulfed bacteria
and fungi, find its way from the phagosome to the cytosol to
cause oxidation of p50 and how this suppresses the in-
flammasome complex. The ROS detection techniques em-
ployed by Warnatsch et al. (48) fail to provide definitive
evidence for phagosome ROS production or subsequent
phagosome membrane permeation of any particular ROS. In
fact, luminol and isoluminol were used to measure total ROS
and extracellular ROS, respectively. Luminol is less polar
and less hydrophilic than isoluminol, is capable of crossing
biological membranes, and is suitable for detecting both in-
tracellular and extracellular ROS. By contrast, isoluminol
only slightly permeates cell membranes, due to its polar and
hydrophilic nature, although its internalization into phago-
somes or endosomes cannot be ruled out. Therefore, one
cannot make the definitive conclusion that isoluminol is
FIG. 2. Schematic representation of extracellular ROS
production via NOX2 oxidase. Large bacteria and fungi
cause frustration of neutrophils resulting in extracellular
ROS production. Also shown is extracellular H2O2 perme-
ating plasma membrane via aquaporin channels. Color
images are available online.
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predominantly measuring ROS in the extracellular space.
Even the suppression of the isoluminol chemiluminescence
by the ‘‘so-called’’ extracellular scavengers such as SOD and
catalase does not provide definitive evidence for extracellular
ROS production because both SOD and catalase are readily
internalized by endocytosis. Despite ongoing uncertainties in
this field, the study by Warnatsch et al. (48) highlights some
exciting developments in the field of redox compartmenta-
lized signaling and an evident gap in the knowledge base for
this fundamental biological process.
The type of ROS influencing intracellular targets within
the cytosol is also undefined. Superoxide, which is anionic,
will most likely be confined within the phagosome, although
it may permeate the phagosomal membrane via specialized
anionic Cl- channels (32). Perhaps, a better candidate is the
direct derivative of superoxide, H2O2, which is not charged
and has the capacity to permeate cell membranes to some
degree. Despite strong evidence that ROS have the capacity
to permeate cell membranes, it still begs the question, why
would a cell utilize such an intricate system to impact on cell
signaling? It seems counterintuitive that a complex enzyme
system, such as NOX2 oxidase, has functionality in the
phagosomal membrane only for the ROS it generates within
the phagosome to ultimately have targets outside this com-
partment? Similarly, it is difficult to imagine why cells would
deliberately generate ROS extracellularly, only for that ROS
to then be shuttled back in, via aquaporin channels, to find
targets within the cell? Moreover, this might be further
hampered by the half-life of any extracellular ROS, which
will likely be strongly influenced by the extracellular milieu.
For instance, superoxide released into the extracellular space
could diffuse rapidly from its site of generation and, at the
same time, be exposed to high levels of extracellular anti-
oxidants such as extracellular SOD. If any H2O2 is generated
by dismutation of superoxide and permeates (or enters by
aquaporin channels) the cell membrane, it will potentially
interact with catalase and glutathione peroxidase in the cy-
tosol. These factors make it unlikely that ROS generated
extracellularly will function as intracellular signaling mole-
cules, although the region of membrane at the cell surface
could be internalized into endosomes to facilitate down-
stream signaling.
Endosomal ROS Production: Virus Driven
Endosomes can be generated by cell surface invagination
and are involved in a wide range of cellular functions, in-
cluding extracellular uptake, enzymatic degradation, intracel-
lular transport, receptor recycling, neurotransmission,
secretion, and intracellular signaling. Endosomes have an in-
tegral role in immune function through, for example, pathogen
phagocytosis and phagosomematuration/degradation, toll-like
receptor (TLR) function, antigen processing, the secretion of
antimicrobial peptides and cytokines, antibody delivery, early
endosome intracellular signaling, and late endosome control of
immune signaling. Given the specific role of endosomes in
innate immune function, it is not surprising that specialist
killing mechanisms have been developed by these functional
compartments to help deal with internalized pathogens.
As eluded to above, historically, there has been a wide
interest into how phagosomal or extracellular NOX2 oxidase-
derived ROS promote the killing of bacteria and fungi.
However, for unknown reasons, less attention has been paid
to virus infection, and as a consequence, several important
key knowledge gaps were recently identified. First, what is
the subcellular compartment for ROS generation in response
to virus infection and what is the relevant enzymatic source of
ROS? Second, what are the molecular targets of ROS and are
these within the specific organelle in which the ROS are
generated? Third, does ROS generation impact on antiviral
signaling and clearance? Finally, is it possible to target this
ROS response to virus infection with organelle-specific
pharmacological inhibitors? Intriguingly, several recent
seminal studies have shown that NOX2 oxidase-derived ROS
do not eliminate viruses in a manner analogous to that for
bacteria and fungi. In contrast, in the absence of NOX2,
viruses such as influenza A cause substantially less lung in-
jury and dysfunction, and this leads to substantially lower
viral burden (16, 23, 25, 41, 43, 46, 47). Therefore, NOX2
oxidase-derived ROS promote rather than inhibit viral in-
fection.We recently provided evidence for how viruses cause
ROS production and how these highly reactive oxygen
molecules actually exacerbate viral disease (43).
It is well understood that after binding to the plasma
membrane, many viruses enter cells by endocytosis. Within
the endosome, viral RNA (or DNA depending on the virus) is
detected by endosomal pattern recognition receptors, in-
cluding TLR3, TLR7, and TLR9 (Fig. 3). The specific re-
ceptor interaction depends on either the Group (I–V) or
genomic orientation (i.e., ssRNA, dsRNA, or DNA) of the
virus, and this triggers an immune response characterized by
type I interferon (IFN) and IL-1b production. We have pro-
vided evidence that NOX2 oxidase is expressed in endo-
somes (43), which is consistent with some observations
showing co-localization of NOX2 and NOX1 with EEA1-
and RAB-5-positive endosomes (21, 24, 29, 32). Importantly,
we showed that viruses which are internalized by endocyto-
sis, including ssRNA viruses irrespective of their classifica-
tion, such as influenza A virus, respiratory syncytial virus,
rhinovirus, Dengue virus and HIV, as well as the DNA
viruses, vaccinia virus, and herpes simplex virus cause acti-
vation of NOX2 oxidase and the production of ROS in en-
dosomes. This response was time-dependent and varied
according to the dose of the virus. Activation of endosomal
NOX2 by ssRNA viruses and DNA viruses was suppressed
by the absence of TLR7 and TLR9, respectively, and were the
result of protein kinase C (PKC) activation. Importantly, we
showed that influenza exposure to wild type (WT) macro-
phages elevated cytosolic PKC activity within 5min, and this
response was absent in TLR7-/- macrophages and in WT
macrophages treated with the inhibitors dynasore or bafilo-
mycin A. The spatial and temporal aspects of endosome ROS
generation in response to virus infection accurately reflect
viral internalization by endocytosis, endosome compart-
mentalization, and pattern recognition receptor signaling
network activation. These studies have defined for the first
time that endosomes are specialized compartments for ROS
production and redox signaling in response to virus infection.
We also showed that endosomal NOX2 oxidase activity
resulted in the suppression of expression of key antiviral
cytokines (43). This was most likely attributed to H2O2, as
inactivation of endosomal H2O2 by exogenous catalase ad-
ministration markedly elevated type I IFN and IL-1b ex-
pression. The effect of catalase was impaired by the
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endocytosis inhibitor Dynasore and by the absence of both
TLR7 and the chaperone UNCB93. We questioned whether
H2O2 that was released by endosomal NOX2 oxidase targets
cysteine residues on protein domains of TLR7 and whether
this regulates receptor activity and causes the exposure of
critical residues upon activation within endosomal compart-
ments. Consistent with this hypothesis, we showed that H2O2
produced by endosomal NOX2 oxidase is likely to modify a
single and evolutionarily conserved unique cysteine residue,
that is, Cys98 located on the endosomal face of TLR7. No-
tably, this can result in dampening of the antiviral cytokine
response and the humoral immune response. Cys98 forms a
disulphide bond with Cys475 on TLR7, which is critical for
receptor activation (52). Potentially, this signifies Cys98 of
TLR7 as a novel redox sensor that may dampen immune
function during viral infections. Subsequently, we demon-
strated that the suppression of ROS production during viral
infection restored immune function and enhanced viral
clearance (43). The confinement of the ROS source (NOX2
oxidase) and ROS target (C98-TLR7) within the endosome is
an important example of redox signaling and is fundamen-
tally consistent with the most likely way that highly reactive
ROS are used to influence cell signaling processes.
Overall, the current status of the field of endosome ROS
biology is still in its infancy, and further investigation will be
required to establish critical biochemical and functional im-
plications of endosomal ROS production in the context of not
only viral infections but also receptor function in general.
This could have even broader relevance for the function of,
and signaling from, plasma membrane-bound receptors such
as G protein-coupled receptors and growth factor receptors,
which are also internalized by endocytosis.
Mitochondrial ROS
Although mitochondria are organelles for energy metab-
olism and accommodate the tricarboxylic acid cycle and
oxidative phosphorylation steps necessary for efficient ATP
generation, it has recently been demonstrated that mito-
chondria are also critical hubs for the regulation of the im-
mune response following pathogen exposure that involves
the generation of ROS (Fig. 4) (30, 31). Superoxide is gen-
erated on both sides of the inner mitochondrial membrane
and hence arises in the matrix or the intermembrane space.
The electron flow through the mitochondrial ETC to complex
IV results in their final deposition into molecular oxygen to
form water. However, electrons can also react with oxygen at
sites in the ETC to form superoxide/H2O2. Complexes I and
III are often regarded as the major sites of mitochondrial ROS
(mtROS) production, but up to 10, other mitochondrial en-
zymes also contribute, including complex II. As seen in other
compartments, superoxide is converted to H2O2 by SOD
enzymes, in this instance SOD1, which is expressed in the
intermembrane space, and SOD2, which is expressed in the
matrix. The functional effects of mtROS are varied, but there
has been a great deal of interest in specific effects on innate
immunity.
Mitochondria have recently been touted as critical platforms
for innate immune activation during bacterial and viral in-
fection. For instance, lipopolysaccharide (LPS) exposure
changes the overall phenotype of macrophages toward a
proinflammatory state, and this is most likely due to alterations
in the processes of oxidative phosphorylation occurring in the
mitochondria. LPS causes a switch from oxidative phosphor-
ylation to glycolysis, and this ‘‘collapse’’ of the mitochondria
results in an increase in mitochondrial membrane potential,
and the ‘‘slowing’’ or reversal of electron transport (aka RET)
through the ETC at complex I. This results in significant ele-
vations of superoxide generation at complex I. Succinate is
critical in this process, and its accumulation and oxidation by
succinate dehydrogenase drive mtROS via RET (30).
Several functional consequences of mitochondria ROS
generation have been demonstrated including activation of
the mitochondrial antiviral signaling (MAVS) protein, which
is a key signaling protein activated by the viral RNA sen-
sors retinoic acid inducible gene I (RIG-I) and melanoma
differentiation-associated protein 5 (MDA-5). The locality of
MAVS close to the mitochondrial membrane would be con-
ducive for ROS activation that occurs within its vicinity. This
process activates critical antiviral signaling systems that help
clear viral infections. mtROS can also drive MAVS oligo-
merization, leading to the production of type I interferon,
FIG. 3. Schematic representation of the endosomal
ROS production pathway to virus infection. Viruses that
internalize via endocytosis are sensed by endosomally lo-
cated TLRs, in particular TLR7 for ssRNA viruses and
TLR9 for DNA viruses (for clarity, endosome TLR3 is not
shown). Activation ofTLR7-MyD88mediatesROSgeneration
via PKC, which triggers the phosphorylation of specific serine
residues on the p47phox subunit that promotes the assembly of a
functional NOX2 oxidase enzyme. The H2O2 generated within
endosomal compartments by NOX2 targets cysteine 98 (C98)
on the ectodomain of TLR7. PKC, protein kinase C; TLR, toll-
like receptor. Color images are available online.
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independent of RNA sensing, which suggests that MAVS
might be a key sensor of mtROS that act to promote host
defense and inflammation in general (8). mtROS can also
activate the inflammasome, although this has been an area of
great controversy. This has been largely attributed to a lack of
specific tools to measure ROS and to manipulate ROS pro-
duction from NADPH oxidases and mitochondria. Some of
the early studies suggest that ROS promote inflammasome
activation based on evidence of sensitivity to high concen-
trations of DPI (i.e., 20lM). The sensitivity of DPI was
suggestive of NADPH oxidase, although as mentioned above
this concentration of DPI can be problematic (9). Indeed, a
series of follow-up studies showed that monocytes fromCGD
patients who have defective NOX2 and p22phox (defect in
NOX1–NOX4) had similar inflammasome activity or in
some cases elevated activity (28, 44). These findings suggest
FIG. 4. Schematic representation of the complexities of the various subcellular compartments of ROS production
and ROS targets that impact on immune system function. Viruses that internalize via endocytosis are sensed by
endosomally located TLR7 for ssRNA viruses and TLR9 for DNA viruses. In addition to driving endosomal NOX2 oxidase,
activation of TLR7 drives transcription factors including IRF-7 and NF-jB that are essential for the induction of antiviral
cytokines (IFNa/b) and proinflammatory cytokines (IL-1b, IL-6), respectively. TLR7 mediates ROS generation via PKC,
and the H2O2 generated within endosomal compartments by NOX2 targets the TLR7 cysteine 98 on the ectodomain to
dampen antiviral signaling networks. Large bacteria and fungi can stimulate the production of extracellular superoxide at
the level of the plasma membrane. Alternatively, bacteria and fungi (small) can be internalized via phagocytosis initiating
phagosomal superoxide production by NOX2 oxidase and then conversion to H2O2 and HOCl via MPO (in neutrophils,
mainly). Along with proteases, ROS are thought to ‘‘kill’’ the invading bacteria or fungi. In addition, phagosomal ROS
oxidize the p50 protein subunit of NF-jB leading to ubiquitination and degradation of p50. Within the phagosome,
engagement of bacterial sensors TLR1, TLR2, or TLR4 causes translocation of TRAF to the mitochondria that binds to
ECSIT, facilitating the generation of mtROS to enhance bacterial killing. Mitochondrial H2O2 targets MAVS for activation
of IRF-7 and NF-jB. mtROS may also activate NLRP3 leading to inflammation activation. ECSIT, evolutionarily con-
served signaling intermediate in toll pathways; IFN, interferon; IL, interleukin; IRF-7, interferon regulatory factor 7;
MAVS, mitochondrial antiviral signaling; mtROS, mitochondrial ROS; NF-jB, nuclear factor kappa B; NLRP3, NACHT,
LRR, and PYD domains-containing protein 3; TRAF, tumor necrosis factor receptor-associated factor. Color images are
available online.
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that NOX-derived ROS are either redundant or suppress in-
flammasome activity. Also, consistent with ROS suppressing
the inflammasome, there is evidence that SOD1-deficient
macrophages, which fail to inactivate superoxide, secrete
lower levels of active IL-1b upon inflammasome stimulation.
A potential reason for this is a reversible oxidation of cys-
teines 362 and 397 on caspase-1, suppressing its activity (27).
More recent studies now claim that ROS promote in-
flammasome activity and the consensus that appears to be
forming is that the ROS are mitochondrial in origin (49, 53).
Thus, inhibition of complex I or III of the mitochondrial
respiratory chain, which is known to result in ROS genera-
tion, increased NLRP3 inflammasome activation, and this
coincided with NLRP3 and ASC co-localization with mito-
chondria. NLRP3 of the inflammasome complex drives IL-1b
expression, which is an important proinflammatory cytokine
(53). Overall, the accumulation of succinate within the mi-
tochondria due to LPS (and bacterial infection) and TLR1,
TLR2, and TLR4 activation resulting in mtROS production
represents an important process that reprograms macro-
phages, such that they are no longer ATP generators but
mtROS generators, which would serve them well for pro-
moting an acute inflammation in response to infection.
mtROS have also been suggested to regulate phagosomal
ROS levels for antibacterial purposes, although the mecha-
nisms are still undefined. The bacterial sensors TLR1, TLR2,
and TLR4, but not the viral endosome located TLR3, TLR7,
or TLR9, have been shown to stimulate mtROS by triggering
the translocation of the TLR signaling adaptor tumor necrosis
factor receptor-associated factor 6 (TRAF6) to the mito-
chondria, where it associates with the protein ECSIT (evo-
lutionarily conserved signaling intermediate in toll pathways)
and is implicated in mitochondrial respiratory chain assem-
bly (49). The mtROS generated is proposed to be involved in
bacterial killing, by contributing to phagosomal ROS levels
in collaboration with NOX2 oxidase. This still remains a
controversial idea and there is insufficient evidence to de-
finitively support how this would occur. First, there is still an
uncertainty of what is the driving (electrical, chemical) force
for mtROS to traverse the inner and outer mitochondrial
membranes, and then, these membranes to enter the phago-
some where there is such a powerful ROS-generating system,
the NOX2 oxidase, already in place. Second, what is the
identity of the ROS that traverse across these membranes? It
has been suggested to be H2O2, but its fate is governed by
antioxidant enzymes expressed within the mitochondrial
space, cytosol, and other organelles such as peroxisomes, and
this has therefore yet to be directly established. Third, what
are the temporal aspects of mtROS production and do these
coincide with the kinetics of microbial killing due to NOX2
oxidase? In neutrophils, a heavily opsonized particle is taken
into the phagocytic vacuole within 20 s and killing is almost
immediate with NOX2 oxidase activation occurring within
20–45 s of vacuole closure. mtROS production is therefore
unlikely to occur before phagosomal NOX2 oxidase activa-
tion. Indeed, the two key studies implicating TLR1, TLR2,
and TLR4 activation leading to mtROS production only
showed a significant elevation in mtROS after 3, 6, and 16 h
of TLR activation (13, 49). Moreover, the kinases Mst1 and
Mst2 function to control ROS production by regulating mi-
tochondrial trafficking and mitochondrion–phagosome jux-
taposition (13). Mst1 and Mst2 activate Rac GTPase to
promote TLR-triggered assembly of the TRAF6-ECSIT
complex that is required for mitochondrial recruitment to
phagosomes (13). However, even the temporal aspects of
these processes of mitochondrion–phagosome juxtaposition
and Mst1- and Mst2-dependent Rac GTPase activation are
not clear. Fourth, the phagosomal NOX2 oxidase can gen-
erate from *1 to 4 M in the vacuole with the steady-state
concentration estimated to be in the micromolar range. Al-
though, we do not know for sure, it is unlikely that mito-
chondria will generate levels of ROS that will significantly
influence the overall level of ROS in the phagosome.
Immune Responses by Nonphagocytic NADPH
Oxidase Isoforms
The discussion thus far has been centered largely on NOX2
oxidase expressed by immune cells, the reason being that
NOX2 oxidase is the prototypical oxidase that has tradi-
tionally been considered the primary mediator of ROS pro-
duction by the immune system in response to external
pathogens. However, there is accumulating evidence that the
other NADPH oxidase enzyme family members, that is,
DUOX, NOX4, and NOX1, are expressed in epithelium (air-
way and gut) and provide a tissue barrier to danger signals such
as infection with certain bacteria and viruses (12, 38, 45). For
example, Dual oxidase 2 (DUOX2) is the most abundant iso-
form present in the gastrointestinal epithelium, is expressed at
much higher levels than DUOX1, and generates extracellular
ROS to protect against Helicobacter pylori colonization (14).
It is thought that DUOX2 is engaged by TLRs and some in-
tracellular NODs (i.e., NOD2) to provide extracellular H2O2 to
lactoperoxidase to produce antimicrobial hypothiocyanite
ions.Moreover, both DUOX1 and DUOX2 are abundant in the
respiratory epithelium and generate high levels of extracellular
H2O2 to exert antibacterial and antiviral responses, although
the mechanisms are not well characterized (17, 20, 45). Thus
far, the evidence implicates DUOX2 as the predominant
functionally active antibacterial and antiviral DUOX in the
airways. For example, influenza A virus infection has been
shown to lead to a coordinated DUOX2 upregulation and
DUOX-mediated ROS generation. Interference with H2O2
production and ROS signaling by oxidase inhibition or H2O2
decomposition augmented influenzaA virus (IAV) replication.
A nuclear pool of DUOX enzymes participated in the regu-
lation of the spliceosome, which promotes alternative splicing
of viral transcripts and controls the assembly of viable virions.
In vivo silencing of DUOX increased the viral load on intra-
nasal infectionwith 2009 pandemicH1N1 influenza virus (40).
In separate studies, overexpression of DUOX2 suppressed
influenza A virus replication in the nasal epithelium, and this
was associated with elevations in the viral sensors RIG-I,
MDA-5, and type I IFNs, suggesting an important antiviral and
protective role for DUOX2-derived ROS against IAV-induced
morbidity (16, 18, 20). However, the issues raised above of
how extracellular ROS influence intracellular signaling
systems apply equally strongly to ROS generated by
DUOX enzymes. Indeed, DUOX-derived H2O2 causes re-
versible cysteine oxidation of critical proteins such as
nonreceptor TK Src and epidermal growth factor receptor
(45). Importantly, these mechanisms are largely unaffected
by extracellular catalase (45), suggesting that DUOX-
dependent signaling originates primarily from activation of
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intracellularly localized DUOX1 such as at ER membranes
or perhaps from internalized enzyme in intracellular com-
partments, such as endosomes.
On the contrary, influenza virus replication in lung epi-
thelial cells was shown to be dependent on NOX4-derived
ROS that activates redox-sensitive intracellular pathways,
including p38 and ERK1/2 MAP kinases (2). The activation
of these pathways by NOX4 was proposed to promote in-
fluenza infection. While the study by Amatore et al. provides
evidence for a virus-dependent elevation in NOX4 mRNA
expression and somewhat modest elevations in ROS, the
upregulation of NOX4 protein appears to not have been fully
validated, given that the NOX4 commercially available an-
tibodies are generally not recommended for use (1) and the
precise antibody used by Amatore et al. was not described.
The subcellular localization of NOX4 is a somewhat con-
tentious issue. There is consensus that NOX4 resides in the
ER forming a heterodimer with p22phox, which is critical for
its activity. However, less substantiated is mitochondrial
expression of NOX4 (5, 6). At this site, NOX4 is thought to
act independent of p22phox, and therefore, its regulation is
largely unknown. Overall, there appears to be a lack of in-
formation on the role of NOX4 in pathogen control, partic-
ularly in vivo. This warrants further investigation, but it is
important to keep in mind that NOX4 is clearly distinct from
both NOX1 and NOX2 oxidase, not only from its subcellular
compartmentalization but also that NOX4 functions to gen-
erate H2O2 directly, rather than superoxide. This latter point
alone is likely to substantially influence the redox biology of
NOX4.
NOX1 is highly expressed in the colon, particularly in
epithelial cells, and similar to phagocytic NOX2, NOX1
functions to produce superoxide. Despite its high expression
and the fact that the colon is exposed to a multitude of bac-
teria, antimicrobial host defense response or function has not
been described to date. Instead, NOX1 plays a role in cell
proliferation and in redox signaling in a variety of vascular
endothelial and smooth muscle cells. Finally, while there is
strong evidence for endosomal localization of NOX1 protein
(28), the role of NOX1within this compartment in the context
of pathogen control is completely undefined.
Concluding Remarks
ROS biology has come a long way since the days when
McCord and Fridovich discovered SOD and brought to life
this exciting field (26). This perspective has focused on ROS
biology that pertains to pathogen control and we know now
that ROS are not only involved in these critical immune
system functions but also play a role in many cellular sig-
naling processes both physiological and pathological in na-
ture. There is no doubt that ROS biology is a complex field,
from the many chemical species that exist in nature, the
multitude of enzymes and nonenzymatic systems that gen-
erate them, to the many antioxidant systems that regulate the
overall levels and thus their cellular targets and functions.
Although we have focused on four cellular compartments of
ROS generation, that is, extracellular, phagosomal, en-
dosomal, and mitochondrial, this is a simplistic view that was
taken only to exemplify the point of compartmentalization
because ROS also exist within the nucleus, ER, and cytosol.
Nevertheless, the four focused compartments are important
sites of ROS generation in response to invading pathogens.
An emerging picture can be painted and perhaps we can
suggest a unifying hypothesis: ROS production and signaling
are governed by a specific invading pathogen, that is, bacteria
or fungi in phagosomes and viruses in endosomes, and per-
haps all converge to the powerhouse of the cell, the mito-
chondria, which appears to regulate both antibacterial/fungal
and antiviral signaling networks (Fig. 4). The concept that the
size of the invading pathogen regulates ROS compartmental-
ization is intriguing and perhaps speaks toward an implicit
property of the innate immune system, that is, a nonspecialized,
but powerful means of regulating pathogen control when the
precise identity of the pathogen is not recognized.
Road Map to Future Research Initiatives in ROS Biology
There are still major knowledge gaps in ROS biology and
while the following is not an exhaustive list, these issues need
to be addressed. (i) Are phagosome/endosome ROS also
signaling molecules? (ii) What are the processes that facili-
tate ROS movement across a membrane, what are the driving
forces for this to occur, and perhaps most importantly, what
are the targets for this ROS in the cytosol? Are there other
receptor targets in the endosome that also modulate immune
function? However, if ROS biology is to progress, there
needs to be a stronger push for the use of more sophisticated
approaches to understand this complex biology. Studies that
implicate ROS need to be more specific about what species of
ROS are involved, through more specific ROS detection
probes (15, 18); they must address compartmentalization of
ROS, source of ROS, and target of ROS with biochemical
assays and advanced imaging modalities. Armed with this
type of information, we can address how these processes
occur physiologically and how they contribute to the pa-
thology associated with inflammation due to infection. In-
deed, the study by To et al., exemplifies how knowledge of
ROS compartmentalization can be exploited for the treatment
of viral infection. It demonstrates, following viral infection,
the biochemical pathways leading to ROS production, the
source of ROS (i.e., NOX2 oxidase), the compartment of
ROS production (i.e., endosome), and the subcellular target
of ROS (TLR7) that impact antiviral immunity. With this
information, an endosome-targeted drug delivery system was
developed to block endosome ROS production to virus in-
fection. An innovative molecular targeting system was syn-
thesized, to deliver one of the most specific NOX2 oxidase
inhibitors available that was generated originally by Pagano
and colleagues (i.e., gp91ds-TAT) (35). The endosomally
targeted system composed of gp91ds-TAT conjugated via a
PEG-linker to cholestanol. Strikingly, targeting the biologi-
cal ROS process in endosomes with cholestanol-conjugated
gp91ds-TAT markedly reduced disease severity caused by
influenza A virus infection. Antioxidant supplementation has
been explored to alleviate oxidative stress and the burden of
ROS in many disease states such as cardiovascular disease
and cancer (36). Disappointingly, however, intervention tri-
als with antioxidants have been mostly either ineffective or
even harmful and to a great deal this has tainted the oxidative
stress hypothesis as a culprit disease mechanisms in humans.
To circumvent the concerns regarding antioxidant therapy,
the more current and advanced approach is to use pharma-
cological agents that selectively suppress the activity of ROS
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forming or toxifying enzymes and whose activity or ex-
pression is increased under pathological conditions. We
support this emerging paradigm but would like to advance it
even further and suggest strongly that there should be a push
toward spatial-specific inhibition of ROS production to en-
sure that physiological ROS function is unaffected while
pathological ROS is suppressed.
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Abbreviations Used
ASC¼ apoptosis-associated speck-like protein
containing a caspase recruitment domain
CGD¼ chronic granulomatous disease
DNA¼ deoxyribonucleic acid
DPI¼ diphenyleneiodonium chloride
DUOX2¼ dual oxidase 2
ER¼ endoplasmic reticulum
ECSIT¼ evolutionarily conserved signaling intermediate
in toll pathways









IRF-7¼ interferon regulatory factor 7
LPS¼ lipopolysaccharide
MAVS¼mitochondrial antiviral signaling
MDA-5¼melanoma differentiation-associated protein 5
MPO¼myeloperoxidase
mtROS¼mitochondrial ROS
NADPH¼ nicotinamide adenine dinucleotide phosphate
NF-jB¼ nuclear factor kappa B





PKC¼ protein kinase C
RAC¼ ras-related C3 botulinum toxin substrate
RET¼ reversal of electron transport
RIG-I¼ retinoic acid inducible gene I
RNA¼ ribonucleic acid
ROS¼ reactive oxygen species
SOD¼ superoxide dismutase
TLR¼ toll-like receptor
TRAF¼ tumor necrosis factor receptor-associated
factor
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